Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney Disease
Kidney and Blood Pressure Research · 07.11.2024 · 49 (1) · 1013-1025
DOI: 10.1159/000542267 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 07.11.2024. Verfasst von Felix Keller und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Disease Progression, Epidermal Growth Factor, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Introduction
Diabetic kidney disease (DKD) is a common cause of chronic kidney disease with around 25–40% of patients with diabetes being affected. The course of DKD is variable, and estimated glomerular filtration rate (eGFR) and albuminuria, the currently used clinical markers, are not able to accurately predict the individual disease trajectory, in particular in early stages of the disease. The aim of this study was to assess the association of urine levels of selected protein biomarkers with the progression of DKD at an early stage of disease.
Methods
We measured 22 protein biomarkers using the Mesoscale Discovery platform in 461 urine samples of the PROVALID cohort, an observational study of patients with type 2 diabetes mellitus followed at the primary health care level for a minimum of 4 years. Odds ratios (ORs) were estimated for the effect of marker values above median on fast progression using unadjusted and adjusted logistic regression models. RNA expression at the single-cell level in kidney biopsy samples obtained from a cohort of young persons with type 2 diabetes mellitus was in addition determined for markers showing significant associations with disease progression.
Results
Increased urinary levels of epidermal growth factor (EGF) were linked to lower odds of fast progression (defined as annual eGFR decline greater than 2.58 mL/min per 1.73 m2) with an OR of 0.60 (95% CI: 0.46, 0.78). The association with outcome was even stronger when adjusting for a set of 14 baseline clinical parameters including age, biological sex, eGFR, body mass index, albuminuria, and HbA1c. Elevated urinary levels of fatty acid-binding protein 3 (FABP3) and vascular cell adhesion molecule 1 (VCAM1) were each significantly associated with fast progression with an OR of 1.44 (95% CI: 1.11, 1.87) and an OR of 1.41 (95% CI: 1.08, 1.83), respectively. Enriched expression of EGF and FABP3 was observed in distal convoluted tubular cells and VCAM1 in parietal epithelial cells at single-cell level from biopsies of patients with early DKD.
Conclusion
In summary, we show that lower urinary levels of EGF and higher urinary levels of FABP3 and VCAM1 are significantly associated with DKD progression in early-stage disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
- Department of Nephrology, Medical University of Vienna, Vienna, Austria.
- Institute of Clinical Biometrics, Centre for Medical Data Science, Medical University of Vienna, Vienna, Austria.
- Department of Internal Medicine, Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
- Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
- Department of Pediatrics and Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Keller, F., Denicolò, S., Leierer, J., Kruus, M., Heinzel, A., Kammer, M., Ju, W., Nair, V., Burdet, F., Ibberson, M., Menon, R., Otto, E., Choi, Y. J., Pyle, L., Ladd, P., Bjornstad, P. M., Eder, S., Rosivall, L., Mark, P. B., …, & Perco, P. (2024). Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney Disease. Kidney and Blood Pressure Research, 49(1), 1013-1025. https://doi.org/10.1159/000542267
Vancouver
Keller F, Denicolò S, Leierer J, Kruus M, Heinzel A, Kammer M, et al. Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney Disease. Kidney and Blood Pressure Research. 2024;49(1):1013-1025. doi:10.1159/000542267
BibTeX
@article{Keller2024,
author = {Keller, Felix and Denicolò, Sara and Leierer, Johannes and Kruus, Maren and Heinzel, Andreas and Kammer, Michael and Ju, Wenjun and Nair, Viji and Burdet, Frederic and Ibberson, Mark and Menon, Rajasree and Otto, Edgar and Choi, Ye Ji and Pyle, Laura and Ladd, Patricia and Bjornstad, Petter M and Eder, Susanne and Rosivall, Laszlo and Mark, Patrick Barry and Wiecek, Andrzej and Heerspink, Hiddo J Lamber and Kretzler, Matthias and Oberbauer, Rainer and Mayer, Gert and Perco, Paul},
title = {Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney Disease},
journal = {Kidney and Blood Pressure Research},
year = {2024},
volume = {49},
number = {1},
pages = {1013--1025},
doi = {10.1159/000542267}
}
EUVIMED